In this population we have already shown by use of an non-physiologic intravenous glucose tolerance test a significant improvement in hyperglycemia and a significant increase in insulin levels [39], which was expected as liraglutide is an insulin secretagogue [12]. This evidence concerns the gene INS and Hyperglycemia.